Sit Investment Associates Inc. Sells 1,573 Shares of Relx Plc (NYSE:RELX)

Sit Investment Associates Inc. trimmed its stake in Relx Plc (NYSE:RELX) by 2.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 72,244 shares of the technology company’s stock after selling 1,573 shares during the period. Sit Investment Associates Inc.’s holdings in Relx were worth $3,281,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Relx by 50.3% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,968,739 shares of the technology company’s stock worth $89,420,000 after purchasing an additional 658,655 shares in the last quarter. Natixis Advisors LLC lifted its position in Relx by 2.8% in the 4th quarter. Natixis Advisors LLC now owns 1,202,592 shares of the technology company’s stock worth $54,622,000 after buying an additional 32,739 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in Relx in the fourth quarter worth approximately $44,516,000. JPMorgan Chase & Co. grew its position in Relx by 14.6% during the third quarter. JPMorgan Chase & Co. now owns 826,481 shares of the technology company’s stock valued at $39,225,000 after acquiring an additional 104,999 shares during the last quarter. Finally, O Shaughnessy Asset Management LLC raised its stake in shares of Relx by 5.4% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 407,376 shares of the technology company’s stock worth $18,503,000 after acquiring an additional 21,040 shares in the last quarter. 15.02% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. StockNews.com lowered shares of Relx from a “buy” rating to a “hold” rating in a report on Tuesday, March 4th. Redburn Atlantic assumed coverage on Relx in a report on Wednesday, January 8th. They issued a “buy” rating on the stock. Barclays upgraded Relx from an “equal weight” rating to an “overweight” rating in a report on Friday, March 14th. Finally, The Goldman Sachs Group assumed coverage on Relx in a research note on Wednesday, March 26th. They issued a “buy” rating on the stock. One investment analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Relx has an average rating of “Buy”.

Relx Price Performance

RELX stock opened at $48.21 on Monday. The stock has a market capitalization of $89.48 billion, a price-to-earnings ratio of 25.92, a PEG ratio of 2.73 and a beta of 0.84. The firm’s 50-day moving average price is $49.62 and its two-hundred day moving average price is $47.92. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. Relx Plc has a 12-month low of $40.25 and a 12-month high of $51.99.

Relx Increases Dividend

The firm also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Friday, May 9th will be given a dividend of $0.5586 per share. This is a positive change from Relx’s previous semi-annual dividend of $0.23. The ex-dividend date is Friday, May 9th. This represents a yield of 1.6%. Relx’s dividend payout ratio is presently 59.68%.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.